Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Receives FDA Clearance Of Cellvizio 100 Series

Jan 27 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES RECEIVES FDA 510(K) CLEARANCE OF
CELLVIZIO® WITH A FLUORESCENT DYE, FLUORESCEIN, AS DRUG DEVICE
COMBINATION

Source text for Eikon:  ID:nBw6Zb2F7a 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Mauna Kea Technologies SA

See all news